Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-develops-novel-retrievable-nanorobots-for-targeted-and-enhanced-thrombolysis
https://www.med.cuhk.edu.hk/press-releases/cuhk-develops-novel-retrievable-nanorobots-for-targeted-and-enhanced-thrombolysis

CUHK develops novel retrievable nanorobots for targeted and enhanced thrombolysis potentially saving stroke patients from brain damage

CUHK develops novel retrievable nanorobots

CUHK has developed magnetic tissue plasminogen activator (tPA)-anchored (tPA-nbots) to treat ischemic stroke. It demonstrates potential to benefit patients by reducing brain damage and minimising side effects. The team also succeeded in using laser speckle contrast imaging (LSCI) guidance for real-time tracking and delivery of nanorobots and instant monitoring the bloodstream, providing a novel approach for nanorobots-based endovascular intervention therapy.

(From left) Professor Simon Yu Chun-ho, Emeritus Professor in the Department of Imaging and Interventional Radiology at CU Medicine; Professor Zhang Li, Professor in the Department of Mechanical and Automation Engineering, CUHK; Dr Bonaventure Ip Yiu-ming, Assistant Professor in the Department of Medicine and Therapeutics at CU Medicine; Professor Tony Chan Kai-fung, Research Assistant Professor of the Chow Yuk Ho Technology Centre for Innovative Medicine; and Professor Thomas Leung Wai-hong, Head of the Division of Neurology and Lee Quo Wei Professor of Neurology in CU Medicine’s Department of Medicine and Therapeutics

A cross-disciplinary research team from The Chinese University of Hong Kong (CUHK) has developed magnetic tissue plasminogen activator (tPA)-anchored nanorobots (tPA-nbots) to treat ischemic stroke. The novel technology exhibits a thrombolysis rate 5 to 20 times faster than traditional treatment and capabilities in recanalising more distal and smaller branches. It demonstrates potential to benefit patients by reducing brain damage and minimising side effects. The team also succeeded in using laser speckle contrast imaging (LSCI) guidance for real-time tracking and delivery of nanorobots and instant monitoring the bloodstream, providing a novel approach for nanorobots-based endovascular intervention therapy. Study results have been published in the international journals Science Advances and Science Robotics.

 

Timely and precise intervention increases the potential for stroke recovery

Stroke ranks as the second-leading global cause of death and is the most common cause of adult long-term physical or cognitive disability. tPA is a drug commonly used to dissolve occlusive clots (thrombolysis), restoring blood flow in patients with acute ischemic stroke. However, the unfocused diffusion of high-dose tPA over the whole body undermines the effectiveness of clot lysis and poses a risk of systemic and brain hemorrhage during treatment.

 

Prof Thomas Leung

Professor Thomas Leung emphasises the importance of prompt and timely re-opening of occluded blood vessels, resuming blood perfusion to the ischemic brain after stroke. 

Professor Thomas Leung Wai-hong, Head of the Division of Neurology and Lee Quo Wei Professor of Neurology in CU Medicine’s Department of Medicine and Therapeutics, emphasised the importance of prompt and timely re-opening of occluded blood vessels, resuming blood perfusion to the ischemic brain. He stated, “Without treatment, brain cells die at an alarming rate of 1.9 million every minute from stroke onset. While we can now access the main stem of the brain arteries and remove the occlusive clots through catheters, the technological bottleneck is recanalising more distal and smaller branches that are equally vital in preserving brain function. One key challenge is how we can accomplish this goal in a safe and effective manner.”
Fast recanalisation by retrievable tPA-nbots for enhanced thrombolysis

To address these challenges, a research team with members from the Department of Mechanical and Automation Engineering at the Faculty of Engineering, the Department of Imaging and Interventional Radiology, and the Department of Medicine and Therapeutics at CU Medicine jointly developed retrievable magnetic tPA-nbots. By deploying a tPA-nbot-loaded catheter to the thrombus site, the tPA-nbot microswarm is remotely actuated to the blood clot within vessels of submillimetre size, initiating the tPA-mediated thrombolysis process. After the blood clot is lysed, the tPA-nbots will be guided back for retrieval, ensuring biomedical safety.

 

Professor Zhang Li from the Department of Mechanical and Automation Engineering explained, “The size of tPA-nbots (~300 nm) allows them to be navigated to the thrombus site within the narrow distal blood vessels. The enhanced, localised delivery can prevent high-dose tPA from being circulated in the body, reducing the possibility of systemic and brain hemorrhage. Even with the reduced dosage, the tPA-nbots with both mechanical and chemical etching exhibit a thrombolysis rate 5 to 20 times faster than traditional treatment and save abundant recanalisation time, potentially saving patients from heavy brain damage.”

 

Professor Simon Yu Chun-ho, Emeritus Professor in the Department of Imaging and Interventional Radiology at CU Medicine, explained, “This novel treatment system can potentially deploy nanorobots to the exact location of the thrombus in peripheral and small arteries, which are hardly accessible with catheters alone. Although many technical issues remain to be solved before this technology can be applied in clinical practice, I believe we have taken an important step in the right direction.”

 

Prof Zhang Li

Professor Zhang Li explains that the tPA-nbots can be navigated to the thrombus site within the narrow distal blood vessels. The enhanced, localised delivery can prevent high-dose tPA from being circulated in the body, reducing the possibility of systemic and brain hemorrhage, and potentially saving patients from heavy brain damage.

Prof Simon Yu

Professor Simon Yu explains that the novel treatment system can potentially deploy nanorobots to the exact location of the thrombus in peripheral and small arteries, which are hardly accessible with catheters alone.

 

Tracking and navigation of microswarm under LSCI to ensure delivery efficiency and biomedical safety

To overcome the limitations of current imaging methods in imaging size and spatial-temporal resolution, the team has proposed a strategy using LSCI to enable in vivo real-time tracking and navigation of nanorobots in the endovascular system. LSCI can monitor the changes in the bloodstream within the area of interest and assess reperfusion status after an ischemic stroke. It ensures delivery efficiency and biomedical safety in complex vascular environments, allowing monitoring and analysis of the thrombolysis process, including changes to the state of the blood clot.

 

Dr Bonaventure Ip Yiu-ming, Assistant Professor in the Department of Medicine and Therapeutics at CU Medicine, commented, “Real-time monitoring of the behaviour of nanorobots under physiological conditions is a crucial step to prove their safety and effective delivery. By employing LSCI, we were able to observe and track the movement of nanorobots in both stagnant and flowing blood environments in vessel models, placenta and small animals. This visualisation marks a critical milestone in refining the dose of nanorobots and the distance, strength and angulation of the magnetic field applied. It is essential to carefully optimise these parameters before implementing the technology in humans.”

 

Professor Tony Chan Kai-fung, Research Assistant Professor of the Chow Yuk Ho Technology Centre for Innovative Medicine, added, “The proposed tPA-nbots with high spatial precision provide a promising robotic tool to enhance thrombolysis efficiency and safety, while side effects and treatment time are greatly reduced. It shows the great potential for clinical translation.”

 

Dr Bonaventure Ip

Dr Bonaventure Ip says the research team was able to observe and track the movement of nanorobots in both stagnant and flowing blood environments by employing LSCI. The visualisation marks a critical milestone in refining the dose of nanorobots and the distance, strength and angulation of the magnetic field applied.

Prof Tony Chan

Professor Tony Chan says the proposed tPA-nbots with high spatial precision provide a promising robotic tool to enhance thrombolysis efficiency and safety, it shows the great potential for clinical translation.

 

tPA-nbot

By deploying a tPA-nbot-loaded catheter to the thrombus site, the tPA-nbot microswarm is remotely actuated to the blood clot within vessels of submillimetre size, initiating the tPA-mediated thrombolysis process. After the blood clot is lysed, the tPA-nbots will be guided back for retrieval.

The original studies can be accessed here:
Science Advances: https://doi.org/10.1126/sciadv.adk8970
Science Robotics: https://doi.org/10.1126/scirobotics.adh1978

 

Acknowledgement

This study was supported by the Research Grants Council, the Innovation and Technology Commission, the Multi-scale Medical Robotics Center under InnoHK, the Chow Yuk Ho Technology Centre for Innovative Medicine, the CUHK-SIAT Joint Research Laboratory on Robotics and Intelligent Systems, and the CUHK T Stone Robotics Institute.

 

Fig

Fig.1 Conceptual drawing of the delivery of tPA-nbots for targeted thrombolysis and in situ tPA-nbots retrieval using a catheter-assisted magnetic actuation system.

More Press Releases

CUHK study reveals an elevated stroke risk with switching oral anticoagulants in atrial fibrillation patients who developed breakthrough strokes during anticoagulation therapy

CUHK study reveals an elevated stroke risk with switching oral anticoagulants in atrial fibrillation patients who developed breakthrough strokes during anticoagulation therapy

Research
CUHK develops a novel magnetic helical microrobot with endoscope-assisted delivery for biofilm eradication in ear tubes

CUHK develops a novel magnetic helical microrobot with endoscope-assisted delivery for biofilm eradication in ear tubes

Research
Radiotherapy to Head and Neck Raises Risk for Stroke CUHK Proved Effectiveness of Carotid Angioplasty and Stenting

Radiotherapy to Head and Neck Raises Risk for Stroke CUHK Proved Effectiveness of Carotid Angioplasty and Stenting

Research
Good News for Asian Patients First Local Clinical Study Shows High Success Rate and Effectiveness of Stenting for Intracranial Stenosis in Preventing Ischaemic Stroke

Good News for Asian Patients First Local Clinical Study Shows High Success Rate and Effectiveness of Stenting for Intracranial Stenosis in Preventing Ischaemic Stroke

Research
CUHK Proves the Potent Efficacy of Stenting for Carotid Artery Narrowing and Cardiac Contractility Modulation for Heart Failure

CUHK Proves the Potent Efficacy of Stenting for Carotid Artery Narrowing and Cardiac Contractility Modulation for Heart Failure

Research
CU Medicine and PWH pioneer low-field MRI technology to launch Hong Kong’s first one-stop acute stroke management model

CU Medicine and PWH pioneer low-field MRI technology to launch Hong Kong’s first one-stop acute stroke management model

Research
CU Medicine completes world’s first study evaluating intracerebral hemorrhage treatments for Chinese patients with atrial fibrillation

CU Medicine completes world’s first study evaluating intracerebral hemorrhage treatments for Chinese patients with atrial fibrillation

Research
CUHK celebrates World Brain Day 2022  Calls for prevention of cerebral small vessel disease to lower the risks of stroke and cognitive impairment

CUHK celebrates World Brain Day 2022 Calls for prevention of cerebral small vessel disease to lower the risks of stroke and cognitive impairment

Research
CUHK Research Team Develops an AI System for Detecting COVID-19 Infections in CT with a Privacy Preserving Multinational Validation Study

CUHK Research Team Develops an AI System for Detecting COVID-19 Infections in CT with a Privacy Preserving Multinational Validation Study

Research
CUHK Develops Biohybrid Soft Microrobots with a Rapid Endoluminal Delivery Strategy for Gastrointestinal Diseases

CUHK Develops Biohybrid Soft Microrobots with a Rapid Endoluminal Delivery Strategy for Gastrointestinal Diseases

Research
CUHK Sees Atrial Fibrillation-related Stroke Cases 3 Times Higher Over 15 Years

CUHK Sees Atrial Fibrillation-related Stroke Cases 3 Times Higher Over 15 Years

Research
CUHK Advocates Stringent Control of Cardiovascular Risks for Reopening of Narrowed Brain Arteries - A New Paradigm to Prevent Recurrent Stroke (Available in Chinese only)

CUHK Advocates Stringent Control of Cardiovascular Risks for Reopening of Narrowed Brain Arteries - A New Paradigm to Prevent Recurrent Stroke (Available in Chinese only)

Research
CUHK and PolyU Jointly Introduce TeleStroke for 24-hour Thrombolysis Service at Prince of Wales Hospital

CUHK and PolyU Jointly Introduce TeleStroke for 24-hour Thrombolysis Service at Prince of Wales Hospital

Clinical service
CUHK Proves External Counterpulsation Helps Augment Cerebral Blood Flow among Ischemic Stroke Patients

CUHK Proves External Counterpulsation Helps Augment Cerebral Blood Flow among Ischemic Stroke Patients

Research
CUHK develops an interventional catheterisation-integrated swarming microrobotic platform for aneurysm embolisation treatment: a new non-invasive approach

CUHK develops an interventional catheterisation-integrated swarming microrobotic platform for aneurysm embolisation treatment: a new non-invasive approach

Research
CUHK leading Asia’s battle to improve bile duct cancer survival rates by developing a novel combinational strategy in clinical trial

CUHK leading Asia’s battle to improve bile duct cancer survival rates by developing a novel combinational strategy in clinical trial

Research
CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

Research
CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

Research
CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

Research
CUHK Launches a Population-based Programme to Evaluate and Track Brain Health Status  of 5,000 Hong Kong Residents for Free

CUHK Launches a Population-based Programme to Evaluate and Track Brain Health Status of 5,000 Hong Kong Residents for Free

Research
CUHK Deepening Ties with World Leading Institutes for Transdisciplinary Medical Robotics Research to Reshape the Future of Diagnosis and Treatment

CUHK Deepening Ties with World Leading Institutes for Transdisciplinary Medical Robotics Research to Reshape the Future of Diagnosis and Treatment

International collaboration
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
CUHK Proves Prostate Artery Embolization Effective for Benign Prostatic Hyperplasia

CUHK Proves Prostate Artery Embolization Effective for Benign Prostatic Hyperplasia

Research
CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

International collaboration
CUHK Professor Receives World Honour For Stroke Services Pioneering an Innovative 3-in-1 Multi-Target Therapy to Repair Damaged Brain After Stroke and Enhance Functional Recovery

CUHK Professor Receives World Honour For Stroke Services Pioneering an Innovative 3-in-1 Multi-Target Therapy to Repair Damaged Brain After Stroke and Enhance Functional Recovery

Awards and honors
CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

Research
CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

Research
CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

Clinical service
CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

Clinical service
CUHK Advocates Atrial Fibrillation Screening and Drug Education to Reduce Risk of Stroke among Elderly

CUHK Advocates Atrial Fibrillation Screening and Drug Education to Reduce Risk of Stroke among Elderly

Clinical service
CUHK Reveals Effectiveness of TEA for Treating Liver Cancer with a 70% Chance of Completely Destroying Tumor

CUHK Reveals Effectiveness of TEA for Treating Liver Cancer with a 70% Chance of Completely Destroying Tumor

Research
CUHK Research Reveals that Stroke Triggers Alzheimer’s Dementia Risk of Alzheimer’s Dementia Can be Reduced by Enhancing Vascular Health

CUHK Research Reveals that Stroke Triggers Alzheimer’s Dementia Risk of Alzheimer’s Dementia Can be Reduced by Enhancing Vascular Health

Research
CUHK Establishes New Hybrid Cardiovascular Operating Theatre and Multidisciplinary Team Significantly Reducing Operation Time and Risk of Thoracic Aortic Surgery

CUHK Establishes New Hybrid Cardiovascular Operating Theatre and Multidisciplinary Team Significantly Reducing Operation Time and Risk of Thoracic Aortic Surgery

Clinical service
CUHK New Research Reveals Better Efficacy of New Oral Anticoagulant for Stroke Prevention in Asian Patients with Atrial Fibrillation

CUHK New Research Reveals Better Efficacy of New Oral Anticoagulant for Stroke Prevention in Asian Patients with Atrial Fibrillation

Research
Dr. Lui Che Woo Distinguished Professor Public Lecture by Prof. Steven C. Cramer on Brain Repair after Stroke

Dr. Lui Che Woo Distinguished Professor Public Lecture by Prof. Steven C. Cramer on Brain Repair after Stroke

Education
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research
CUHK Develops an Automatic Retinal Image Analysis System to Help Diabetes Patients and Elderly Prevent Stroke

CUHK Develops an Automatic Retinal Image Analysis System to Help Diabetes Patients and Elderly Prevent Stroke

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.